Gene Variant Raises Heart Disease Risk in Many Black Adults

Adults of African ancestry may carry a common CD36 variant that standard cardiomyopathy genetic panels do not yet test for.

Updated on Nov. 3, 2026 in Heart Disease

Isometric editorial illustration of a solid oxblood heart silhouette beside a row of glass test tubes on a cream lab bench in deep teal and slate tones.
Cleveland Clinic-led researchers identified a CD36 gene variant found in about 17% of people of African ancestry that current cardiomyopathy genetic panels do not test for. AI Illustration. Upload story photo >

Live Poll

Should routine genetic heart testing include variants common in people of African ancestry?

Cleveland Clinic-led researchers identified a CD36 gene variant as a leading known genetic cause of dilated cardiomyopathy, a disease that thins and enlarges the heart's chambers, in people of African ancestry. The variant is found in about 17% of people of African ancestry, and the team is working to add testing for it to clinical practice.

Why it matters

Dilated cardiomyopathy often produces fatigue and shortness of breath that can be mistaken for other conditions, so a known genetic contributor could help clinicians identify at-risk patients earlier. The CD36 variant is not included in standard cardiomyopathy genetic panels today, which is why its absence from routine testing has mattered for this population.

This genetic association study analyzed 82,623 individuals of African ancestry across four U.S. datasets, with an average participant age of 53. Carriers of two copies of the CD36 risk variant had approximately fivefold higher odds of dilated cardiomyopathy compared with noncarriers.

The players

Cleveland Clinic

Cleveland Clinic is a major academic medical center known for cardiovascular care and research, and it led the study identifying the CD36 variant.

The details

The CD36 variant is common among people of African ancestry and virtually absent in people of European ancestry, which may help explain disparities in how the condition appears across populations. Researchers identified the variant through analysis of genetic data from the large combined sample of individuals of African ancestry. Because the variant is not part of current standard testing panels, individuals may not learn of this risk unless testing specifically includes it.

Timeline

  1. November 3, 2026: Article published reporting the CD36 variant and heart failure link.

Health Landscape

Current genetic testing panels for cardiomyopathy do not include the CD36 variant, leaving a known contributor outside standard screening. Adding it would bring population-specific genetic risk into routine cardiomyopathy evaluation.

If you are of African ancestry and have unexplained fatigue or shortness of breath, it may be worth raising a family history of heart muscle disease with your doctor. Ask whether genetic testing that includes the CD36 variant is available to you, since standard panels do not currently include it.

The takeaway

A common genetic variant can meaningfully raise the risk of dilated cardiomyopathy in people of African ancestry, yet it is missing from standard testing. If you have a family history of heart muscle disease, bring it up with your physician and ask whether broader genetic testing is appropriate.

Further reading

For more on the conditions behind this finding, explore our Heart Disease coverage.

Source note: This article includes information reported by Cleveland.

Live Poll

Should routine genetic heart testing include variants common in people of African ancestry?